Search

Showing 61 - 70 of 430 results.

Clinical Data

INSPIRED BY PATIENTS. MADE POSSIBLE BY YOU. TriClip TEER has shown meaningful outcomes in both real-world and randomized clinical data. The bRIGHT study and TRILUMINATE™ Pivotal trial demonstrated
Features

The TriClip™ G4 Transcatheter Edge-to-Edge Repair System empowers you with stable navigation and precise delivery2 for complex conditions.
Overview

WATCH HOW MITRACLIP™ TEER TRANSFORMED LUCA'S LIFE FIND OUT MORE: DOWNLOAD FLYER *The testimonial does not provide any indication, guide, warranty or guarantee as to the response patients may ha
Overview

HEART FAILURE IS AFFECTING A GROWING NUMBER OF PATIENTS With the complexity and rise in prevalence of heart failure, the Heart Failure Association of the European Society of Cardiology aims to make
Overview

FIND OUT MORE: AMPLATZER™ DUCT OCCLUDERS AMPLATZER™ PICCOLO™ OCCLUDER ABBOTT EVENTS PremiClose is the only worldwide symposium focused on PDA closure in preterm infants. The goal
Guidelines

2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPED IN COLLABORATION WITH THE EUROPEAN ASSOCIATION OF CARDIOTHORACIC SURGERY (EACTS)4-7 ACCESS TO
Prevention

AF AND THE CHALLENGES OF MEDICATION Many patients at risk of stroke want an alternative to oral anticoagulants (OACs), for example, warfarin and non-vitamin K oral anticoagulants (NOACs).7 40% Do N
Overview

Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC Practice Guidelines for the Management of Patients with Atrial Fibrillation. Circulation. 2006;114(7):700–752. https://doi.org/10.1161/CIRCULATIO
Overview

FIND OUT MORE: AMPLATZER™ TALISMAN™ PFO OCCLUDER PFO CLOSURE: BEHIND THE NUMBERS Ischemic strokes are of unknown cause5 Of patients with an ischemic stroke of unknown cause have a PFO4 P